Cargando…

Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report

Crizotinib, an oral ATP-competitive tyrosine kinase inhibitor (TKI), has shown significant activity against advanced non-small cell lung cancer (NSCLC) tumors harboring mesenchymal-epithelial transition (MET) amplification or exon 14 mutation. Methods to detect MET alteration includes immunohistoche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Peng, Liu, Li, Liu, Yutao, Zhang, Tao, Guo, Lei, Li, Weihua, Ying, Jianming, Yang, Lin, Gao, Shugeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798553/ https://www.ncbi.nlm.nih.gov/pubmed/35116804 http://dx.doi.org/10.21037/tcr.2019.03.14

Ejemplares similares

Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative
por: Ma, Di, et al.
Publicado: (2016)

Subjecting appropriate lung adenocarcinoma samples to next‐generation sequencing‐based molecular testing: challenges and possible solutions
por: Li, Weihua, et al.
Publicado: (2018)

ALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Generation Sequencing Testing
por: Canterbury, Carleigh R., et al.
Publicado: (2021)

Cervical adenocarcinoma in situ with negative conization margin: negligible or not?
por: Kang, Sokbom
Publicado: (2011)

Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer
por: Wang, Anqiang, et al.
Publicado: (2019)

Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK‐rearranged non‐small‐cell lung cancer
por: Song, Peng, et al.
Publicado: (2019)

Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
por: Gao, Yang, et al.
Publicado: (2016)

Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization
por: Schmitt, Christina, et al.
Publicado: (2021)

Comparison of Next-Generation Sequencing and Fluorescence In Situ Hybridization for Detection of Segmental Chromosomal Aberrations in Neuroblastoma
por: Kim, Eojin, et al.
Publicado: (2021)

Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
por: Ota, Takayo, et al.
Publicado: (2019)

Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells
por: Zhang, Yingzi, et al.
Publicado: (2021)

Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
por: Gu, Fei-fei, et al.
Publicado: (2016)

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report
por: Qin, Ruo-Yan, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer
por: Xu, Yu, et al.
Publicado: (2017)

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program
por: Aparicio, Thomas, et al.
Publicado: (2021)

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.
por: Haapasalo, H., et al.
Publicado: (1996)

NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling
por: Zhang, Jianchao, et al.
Publicado: (2016)

Pros and Cons for Fluorescent in Situ Hybridization, Karyotyping and Next Generation Sequencing for Diagnosis and Follow-up of Multiple Myeloma
por: Ikbal Atli, E, et al.
Publicado: (2021)

Fluorescent in situ Hybridization on Mitotic Chromosomes of Mosquitoes
por: Timoshevskiy, Vladimir A., et al.
Publicado: (2012)

Sexing of Dog Sperm by Fluorescence In Situ Hybridization
por: OI, Maya, et al.
Publicado: (2012)

Fluorescence In Situ Hybridization (FISH) and Its Applications
por: Shakoori, Abdul Rauf
Publicado: (2017)

Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
por: Zhang, Xiangming, et al.
Publicado: (2023)

Alectinib versus crizotinib in ALK‐positive advanced non‐small cell lung cancer and comparison of next‐generation TKIs after crizotinib failure: Real‐world evidence
por: Wang, Yurong, et al.
Publicado: (2022)

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy
por: Ryu, Woo Kyung, et al.
Publicado: (2022)

Application of Fluorescence In Situ Hybridization Assisted by Fluorescence Microscope in Detection of Her2 Gene in Breast Cancer Patients
por: Lu, Fang, et al.
Publicado: (2022)

Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?
por: Kim, Dong Uk
Publicado: (2020)

Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
por: Peterson, Jess F., et al.
Publicado: (2019)

Visualizing the Needle in the Haystack: In Situ Hybridization With Fluorescent Dendrimers
por: Gerhart, Jacquelyn, et al.
Publicado: (2004)

Fluorescence in situ hybridization (FISH) Protocol in Human Sperm
por: Sarrate, Zaida, et al.
Publicado: (2009)

Construction of repeat-free fluorescence in situ hybridization probes
por: Swennenhuis, Joost F., et al.
Publicado: (2012)

Detection of dengue group viruses by fluorescence in situ hybridization
por: Raquin, Vincent, et al.
Publicado: (2012)

Rapid micro fluorescence in situ hybridization in tissue sections
por: Huber, D., et al.
Publicado: (2018)

Fluorescence in situ hybridization in surgical pathology: principles and applications
por: Cheng, Liang, et al.
Publicado: (2017)

Fluorescence In Situ Hybridization (FISH) Signal Analysis Using Automated Generated Projection Images
por: Wang, Xingwei, et al.
Publicado: (2012)

A Novel c-Mesenchymal-Epithelial Transition Factor Intergenic Fusion Response to Crizotinib in a Chinese Patient With Lung Adenocarcinoma: A Case Report
por: Liang, Hongge, et al.
Publicado: (2021)

Fluorescence In situ Hybridization: Cell-Based Genetic Diagnostic and Research Applications
por: Cui, Chenghua, et al.
Publicado: (2016)

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma
por: Zhang, Jing, et al.
Publicado: (2016)

Fluorescence quenching by high-power LEDs for highly sensitive fluorescence in situ hybridization
por: Tsuneoka, Yousuke, et al.
Publicado: (2022)

Oligonucleotide Fluorescence In Situ Hybridization: An Efficient Chromosome Painting Method in Plants
por: Harun, Arrashid, et al.
Publicado: (2023)

Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
por: Suydam, Camille, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3mbs77slu9o34d7ebcl9kggihj